Endoscopic retrograde cholangiopancreatography: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(20 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{Editor help}}
{{Editor help}}
Assistant editor in chief: [[User:Rim Halaby|Rim Halaby]]


[[Image:Pigment stone extraction.png|thumb|right|Duodenoscopic image of two [[gallstone|pigment stones]] extracted from [[common bile duct]] after sphincterotomy]]
[[Image:Pigment stone extraction.png|thumb|right|Duodenoscopic image of two [[gallstone|pigment stones]] extracted from [[common bile duct]] after sphincterotomy]]
[[Image:ERCP stone.jpg|right|thumb|Fluoroscopic image of [[common bile duct]] [[choledocholithiasis|stone]] seen at the time of ERCP.  The stone is impacted in the distal common bile duct.]]


==Overview==
==Overview==
Line 11: Line 12:
==Procedure==
==Procedure==
*ERCP is a technique that combines video endoscopy and fluoroscopy. It is usually done in an outpatient setting and the patient is often sedated or anaesthetized. A flexible side viewing camera ([[endoscope]]) is inserted through the mouth, down the esophagus, into the stomach, through the [[pylorus]] into the [[duodenum]]. The [[ampulla of Vater]], which is the opening of the common [[bile duct]] and pancreatic duct,  is identified. This region can be directly visualized with the endoscopic camera while various procedures are performed.  
*ERCP is a technique that combines video endoscopy and fluoroscopy. It is usually done in an outpatient setting and the patient is often sedated or anaesthetized. A flexible side viewing camera ([[endoscope]]) is inserted through the mouth, down the esophagus, into the stomach, through the [[pylorus]] into the [[duodenum]]. The [[ampulla of Vater]], which is the opening of the common [[bile duct]] and pancreatic duct,  is identified. This region can be directly visualized with the endoscopic camera while various procedures are performed.  
*Once the ampulla is ientified, a plastic catheter or ''[[Wikt:cannula|cannula]]'' is inserted through the ampulla, and radiocontrast is injected into the bile ducts, and/or, pancreatic duct.[[Fluoroscopy]], which uses X-rays,  is used to locate strictures, blockages, or leakage of bile into the [[peritoneum]] (the abdominal cavity) as well as to guide therapeutic procedures.
*Once the ampulla is identified, a plastic catheter or ''[[Wikt:cannula|cannula]]'' is inserted through the ampulla, and radiocontrast material is injected into the bile ducts, and/or, pancreatic duct. [[Fluoroscopy]], which uses X-rays,  is used to locate strictures, blockages, or leakage of bile into the [[peritoneum]] as well as to guide therapeutic procedures.
*A wire and balloon may be passed into the bile duct, then inflated in order to expand the opening of the bile duct to allow passage of [[gallstones]]. When needed, the opening of the ampulla can be enlarged with an electrified wire ([[sphincterotome]]) and access into the bile duct obtained so that [[gallstones]] may be removed or other therapy performed.
*A wire and balloon may be passed into the bile duct, then inflated in order to expand the opening of the bile duct to allow passage of [[gallstones]]. When needed, the opening of the ampulla can be enlarged with an electrified wire ([[sphincterotome]]) and access into the bile duct obtained so that [[gallstones]] may be removed or other therapy performed.
*Other procedures associated with ERCP include the trawling of the common bile duct with a basket or balloon to remove [[gallstones]] and the insertion of a plastic [[stent]] to assist the drainage of bile. Also, the pancreatic duct can be cannulated and stents be inserted.
*Other procedures associated with ERCP include the trawling of the common bile duct with a basket or balloon to remove [[gallstones]] and the insertion of a plastic [[stent]] to assist the drainage of bile. Also, the pancreatic duct can be cannulated and stents be inserted.
===Equipment===
*Catheters
**Cannulation catheter
**Dilator catheter
**Manometry catheter
**Nasobiliary drainage catheter
**Nasopancreatic drainage catheter
**Brush cytology catheter
*Wires
*Biopsy forceps
*Stone extraction tools
**Balloon
**Stone retrieval baskets
**Mechanical lithotriptor
*Stents
**Plastic stents
**Metal stent
**Covered metal stent
**Uncovered metal stent<ref>asge.org</ref>


==Indications==
==Indications==
Line 21: Line 41:
*'''Role of ERCP:'''
*'''Role of ERCP:'''
**Dilatation of the sphincter of Oddi by endoscopic sphincterectomy and subsequent stone extraction.
**Dilatation of the sphincter of Oddi by endoscopic sphincterectomy and subsequent stone extraction.
***Stone removal is done by sofogarty type balloons or wire baskets.
***Stone removal is done by balloons or wire baskets.
***When the stones are too large to be extracted, lithotripsy can be done to fragment the stones.
***When the stones are too large to be extracted, lithotripsy can be done to fragment the stones.
**Balloon sphincteroplasty is an alternative for sphincterectomy in patients with [[coagulopathy|coagulopathies]].<ref name="pmid15990812">{{cite journal| author=Adler DG, Baron TH, Davila RE, Egan J, Hirota WK, Leighton JA et al.| title=ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. | journal=Gastrointest Endosc | year= 2005 | volume= 62 | issue= 1 | pages= 1-8 | pmid=15990812 | doi=10.1016/j.gie.2005.04.015 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15990812  }} </ref>
**Balloon sphincteroplasty is an alternative for sphincterectomy in patients with [[coagulopathy|coagulopathies]].<ref name="pmid15990812">{{cite journal| author=Adler DG, Baron TH, Davila RE, Egan J, Hirota WK, Leighton JA et al.| title=ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. | journal=Gastrointest Endosc | year= 2005 | volume= 62 | issue= 1 | pages= 1-8 | pmid=15990812 | doi=10.1016/j.gie.2005.04.015 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15990812  }} </ref>
;Shown below is a fluoroscopic image of the common bile duct seen at the time of ERCP.
[[Image:ERCP stone.jpg|center|250px|Fluoroscopic image of [[common bile duct]] [[choledocholithiasis|stone]] seen at the time of ERCP.  The stone is impacted in the distal common bile duct.]]


====Biliary strictures or leak====
====Biliary strictures or leak====
Line 49: Line 71:
**Dilatation and stent placement for the strictures
**Dilatation and stent placement for the strictures
**Pseucdocyst drainage
**Pseucdocyst drainage
====Pancreatic duct leaks====
====Pancreatic duct leaks====
*Pancreatic duct leaks are seen in [[acute pancreatitis]], [[chronic pancreatitis]], trauma or after surgery. If left untreated, pancreatic leaks lead to [[ascites]] and formation of pseudocysts.
*Pancreatic duct leaks are seen in [[acute pancreatitis]], [[chronic pancreatitis]], trauma or after surgery. If left untreated, pancreatic leaks lead to [[ascites]] and formation of pseudocysts.
Line 55: Line 78:
**"Bridging" by reconnecting segments of the pancreatic parenchyma
**"Bridging" by reconnecting segments of the pancreatic parenchyma
====Pancreatic fluid collection====
====Pancreatic fluid collection====
*Pancreatic flui collection can be either in the form of acute pseudocyst, chronic pseudocyst or pancreatic necrosis.
*Pancreatic fluid collection can be either in the form of acute [[pseudocyst]], chronic pseudocyst or pancreatic necrosis.
*'''Role of ERCP''':
*'''Role of ERCP:'''
**Drainage by transpapillary therapy in communicable fluid collections
**Drainage by transpapillary therapy in communicable fluid collections
**Drainage by transgastric or transduodenal therapy in non communicable fluid collections<ref name="pmid15990812">{{cite journal| author=Adler DG, Baron TH, Davila RE, Egan J, Hirota WK, Leighton JA et al.| title=ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. | journal=Gastrointest Endosc | year= 2005 | volume= 62 | issue= 1 | pages= 1-8 | pmid=15990812 | doi=10.1016/j.gie.2005.04.015 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15990812  }} </ref>
**Drainage by transgastric or transduodenal therapy in non communicable fluid collections<ref name="pmid15990812">{{cite journal| author=Adler DG, Baron TH, Davila RE, Egan J, Hirota WK, Leighton JA et al.| title=ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. | journal=Gastrointest Endosc | year= 2005 | volume= 62 | issue= 1 | pages= 1-8 | pmid=15990812 | doi=10.1016/j.gie.2005.04.015 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15990812  }} </ref>
Line 66: Line 89:
**Brush cytology
**Brush cytology
**Biopsy<ref name="pmid15990812">{{cite journal| author=Adler DG, Baron TH, Davila RE, Egan J, Hirota WK, Leighton JA et al.| title=ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. | journal=Gastrointest Endosc | year= 2005 | volume= 62 | issue= 1 | pages= 1-8 | pmid=15990812 | doi=10.1016/j.gie.2005.04.015 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15990812  }} </ref>
**Biopsy<ref name="pmid15990812">{{cite journal| author=Adler DG, Baron TH, Davila RE, Egan J, Hirota WK, Leighton JA et al.| title=ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. | journal=Gastrointest Endosc | year= 2005 | volume= 62 | issue= 1 | pages= 1-8 | pmid=15990812 | doi=10.1016/j.gie.2005.04.015 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15990812  }} </ref>
 
;Shown below is a fluoroscopic image of the pancreatic duct seen at the time of ERCP.
[[Image:ERCP_dilatation.png‎|center|250px|Fluoroscopic image showing dilatation of the pancreatic duct during ERCP investigation. Endoscope is visible.]]
===Diseases of the Ampulla of Vater===
===Diseases of the Ampulla of Vater===
====Ampullary adenoma====
====Ampullary adenoma====
*Role of ERCP:
*'''Role of ERCP:'''
**Snare ampillectomy with biliary or pancreatic sphincterectomy.
**Snare ampillectomy with biliary or pancreatic sphincterectomy.


Line 75: Line 99:
====Hypertonic Sphincter of Oddi====
====Hypertonic Sphincter of Oddi====
*Increased tone of the sphincter of Oddi leads to obstruction of the bile and pancreatic secretion pathway and subsequent symptoms of biliary colic.
*Increased tone of the sphincter of Oddi leads to obstruction of the bile and pancreatic secretion pathway and subsequent symptoms of biliary colic.
*Role of ERCP:
*'''Role of ERCP:'''
**Biliary manometry (diagnostic)
**Biliary manometry (diagnostic)
**Biliary sphincterectomy (therapeutic)<ref name="pmid15990812">{{cite journal| author=Adler DG, Baron TH, Davila RE, Egan J, Hirota WK, Leighton JA et al.| title=ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. | journal=Gastrointest Endosc | year= 2005 | volume= 62 | issue= 1 | pages= 1-8 | pmid=15990812 | doi=10.1016/j.gie.2005.04.015 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15990812  }} </ref>
**Biliary sphincterectomy (therapeutic)<ref name="pmid15990812">{{cite journal| author=Adler DG, Baron TH, Davila RE, Egan J, Hirota WK, Leighton JA et al.| title=ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. | journal=Gastrointest Endosc | year= 2005 | volume= 62 | issue= 1 | pages= 1-8 | pmid=15990812 | doi=10.1016/j.gie.2005.04.015 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15990812  }} </ref>
Line 85: Line 109:
*Recent myocardial infarction
*Recent myocardial infarction
*Inadequate surgical back-up  
*Inadequate surgical back-up  
*History of contrast dye anaphylaxis  
*History of contrast dye anaphylaxis
*High risk of post-sphincterectomy bleeding
 
===Relative Contraindications===
===Relative Contraindications===
*Poor health condition for surgery
*Poor health condition for surgery
Line 111: Line 137:
====Prevention====
====Prevention====
*Substitution of [[ERCP]] with an alternative procedure in high risk patients when the chances of therapeutic benefits are low
*Substitution of [[ERCP]] with an alternative procedure in high risk patients when the chances of therapeutic benefits are low
*Decrease the [[inflammation]] induced by [[ERCP]] by prophylactic administration of [[indomethacin]] and [[diclofenac]] before [[ERCP]]
*Reduction of the [[ERCP]]-induced [[inflammation]] by prophylactic administration of [[indomethacin]] and [[diclofenac]] before [[ERCP]]
*Placement of duct stents in high ridk patients
*Placement of duct stents in high risk patients
*The use of wire guided cannulation before injection of the dye to avoid the dye reaching the pancreas<ref name="pmid22341094">{{cite journal| author=ASGE Standards of Practice Committee. Anderson MA, Fisher L, Jain R, Evans JA, Appalaneni V et al.| title=Complications of ERCP. | journal=Gastrointest Endosc | year= 2012 | volume= 75 | issue= 3 | pages= 467-73 | pmid=22341094 | doi=10.1016/j.gie.2011.07.010 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22341094  }} </ref>
*The use of wire guided cannulation before injection of the dye to avoid the dye reaching the pancreas<ref name="pmid22341094">{{cite journal| author=ASGE Standards of Practice Committee. Anderson MA, Fisher L, Jain R, Evans JA, Appalaneni V et al.| title=Complications of ERCP. | journal=Gastrointest Endosc | year= 2012 | volume= 75 | issue= 3 | pages= 467-73 | pmid=22341094 | doi=10.1016/j.gie.2011.07.010 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22341094  }} </ref>


Line 144: Line 170:
====Criteria====
====Criteria====
*Guidewire induced perforation, or
*Guidewire induced perforation, or
*Luminal perforation at a site remote from the papilla
*Luminal perforation at a site remote from the papilla, or
*The perforation of the ampulla during sphincterectomy
*The perforation of the ampulla during sphincterectomy
====Incidence====
====Incidence====
*The incidence of post-ERCP perforation is between 0.1% and 0.6%.<ref>FreemanML.AdverseoutcomesofERCP.GastrointestEndosc2002;56(6 Suppl):S273-82.</ref>
*The incidence of post-ERCP perforation is between 0.1% and 0.6%.<ref>FreemanML.AdverseoutcomesofERCP.GastrointestEndosc2002;56(6 Suppl):S273-82.</ref>
Line 164: Line 191:
====Risk factors====
====Risk factors====
*Cholangitis:
*Cholangitis:
*Use of combined percutaneous-endoscopic procedures
**Use of combined percutaneous-endoscopic procedures
*Stent placement in malignant strictures
**Stent placement in malignant strictures
*Presence of jaundice
**Presence of jaundice
*Primary sclerosing cholangitis<ref>FreemanML.AdverseoutcomesofERCP.GastrointestEndosc2002;56(6 Suppl):S273-82.</ref>
**Primary sclerosing cholangitis<ref>FreemanML.AdverseoutcomesofERCP.GastrointestEndosc2002;56(6 Suppl):S273-82.</ref>
*Cholecystitis:
**Presence of stones in the [[gallbladder]] and possibly filling of the [[gallbladder]] with contrast during the examination
**Use of self-expandable metal stents
**Incomplete biliary drainage<ref name="Fumex">Fumex F, Coumaros D, Napoleon B, et al. Similar performance but higher cholecystitis rate with covered biliary stents: results from a prospective multicenter evaluation. Endoscopy 2006;38:787-92.</ref>


Cholecystitis:
*Presence of stones in the [[gallbladder]] and possibly filling of the [[gallbladder]] with contrast during the examination
*Use of self-expandable metal stents
*Incomplete biliary drainage ref name="Fumex">Fumex F, Coumaros D, Napoleon B, et al. Similar performance but higher cholecystitis rate with covered biliary stents: results from a prospective multicenter evaluation. Endoscopy 2006;38:787-92.</ref>
====Prevention====
====Prevention====
*Antibiotic prophylaxis covering gram negative bacteria and enterococci should be considered before an [[ERCP]] in patients with known or suspected biliary obstruction in which there is a risk of incomplete drainage by [[ERCP]]. This is usually the case of patients with primary sclerosing cholangitis.<ref name="pmid22341094">{{cite journal| author=ASGE Standards of Practice Committee. Anderson MA, Fisher L, Jain R, Evans JA, Appalaneni V et al.| title=Complications of ERCP. | journal=Gastrointest Endosc | year= 2012 | volume= 75 | issue= 3 | pages= 467-73 | pmid=22341094 | doi=10.1016/j.gie.2011.07.010 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22341094  }} </ref>
*Antibiotic prophylaxis covering gram negative bacteria and enterococci should be considered before an [[ERCP]] in patients with known or suspected biliary obstruction in which there is a risk of incomplete drainage by [[ERCP]]. This is usually the case of patients with primary sclerosing cholangitis.<ref name="pmid22341094">{{cite journal| author=ASGE Standards of Practice Committee. Anderson MA, Fisher L, Jain R, Evans JA, Appalaneni V et al.| title=Complications of ERCP. | journal=Gastrointest Endosc | year= 2012 | volume= 75 | issue= 3 | pages= 467-73 | pmid=22341094 | doi=10.1016/j.gie.2011.07.010 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22341094  }} </ref>
Line 190: Line 217:


==Mortality==
==Mortality==
The mortality rate associated with ERCP is 0.2%.<ref>Loperfido S, Angelini G, Benedetti G, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998;48:1-10.</ref>


==Antibiotic Prophylaxis==
==Antibiotic Prophylaxis==
 
Antibiotic use before ERCP is recommended in:
==ERCP in Special Situations==
*Patients with known or suspected biliary obstruction and in which drainage might not be complete by [[ERCP]] (for example, in patients with a hilar stricture and [[PSC]]) in order to prevent [[cholangitis]].
===ERCP in Pregnancy===
**If biliary drainage is incomplete after an [[ERCP]], antibiotics covering the biliary flora ( enteric gram-negative organisms and enterococci) should be continued following the procedure.
===ERCP in Children===
**If biliary drainage is complete, antibiotics are not recommended after [[ERCP]].
===ERCP in Bariatric Patients===
*Patients with post-transplant biliary strictures whether drainage was complete or not.
*Patients with communicating sterile pancreatic fluid collection such as pancreatic cysts or pseudocysts in order to prevent cyst infection.<ref name="pmid18374919">{{cite journal| author=ASGE STANDARDS OF PRACTICE COMMITTEE. Banerjee S, Shen B, Baron TH, Nelson DB, Anderson MA et al.| title=Antibiotic prophylaxis for GI endoscopy. | journal=Gastrointest Endosc | year= 2008 | volume= 67 | issue= 6 | pages= 791-8 | pmid=18374919 | doi=10.1016/j.gie.2008.02.068 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18374919  }} </ref>


==ERCP Versus MRCP==
==ERCP Versus MRCP==
==Videos==
http://www.youtube.com/playlist?list=PL40886E113559E9E4&feature=plcp


http://www.youtube.com/watch?v=o-L4gdqOuPI&feature=related


==See also==
==See also==

Latest revision as of 03:43, 5 November 2012

Template:Editor help

Assistant editor in chief: Rim Halaby

Duodenoscopic image of two pigment stones extracted from common bile duct after sphincterotomy

Overview

Endoscopic retrograde cholangiopancreatography (ERCP) is a technique that combines the use of endoscopy and fluoroscopy to diagnose and treat certain biliary or pancreatic ductal diseases. ERCP was first introduced in 1968 and was later on accepted as a safe diagnostic and therapeutic tool [1]. Nowadays, as other imaging techniques are evolving and becoming widely used for the diagnosis of diseases of the biliary and pancreatic systems, the use of ERCP became mainly targeted towards therapeutic rather than diagnostic purposes.

ERCP is indicated in biliary tract diseases including choledecholithiasis and benign and malignant biliary strictures, as well as pancreatic diseases including recurrent acute pancreatitis, chronic pancreatitis, pancreatic duct leaks, pancreatic fluid collections and obstructive pancreatic malignancies[2]. There is a variation in the reported rates of complications associated with ERCP, which are mainly pancreatitis, hemorrhage and infection[3].

Procedure

  • ERCP is a technique that combines video endoscopy and fluoroscopy. It is usually done in an outpatient setting and the patient is often sedated or anaesthetized. A flexible side viewing camera (endoscope) is inserted through the mouth, down the esophagus, into the stomach, through the pylorus into the duodenum. The ampulla of Vater, which is the opening of the common bile duct and pancreatic duct, is identified. This region can be directly visualized with the endoscopic camera while various procedures are performed.
  • Once the ampulla is identified, a plastic catheter or cannula is inserted through the ampulla, and radiocontrast material is injected into the bile ducts, and/or, pancreatic duct. Fluoroscopy, which uses X-rays, is used to locate strictures, blockages, or leakage of bile into the peritoneum as well as to guide therapeutic procedures.
  • A wire and balloon may be passed into the bile duct, then inflated in order to expand the opening of the bile duct to allow passage of gallstones. When needed, the opening of the ampulla can be enlarged with an electrified wire (sphincterotome) and access into the bile duct obtained so that gallstones may be removed or other therapy performed.
  • Other procedures associated with ERCP include the trawling of the common bile duct with a basket or balloon to remove gallstones and the insertion of a plastic stent to assist the drainage of bile. Also, the pancreatic duct can be cannulated and stents be inserted.

Equipment

  • Catheters
    • Cannulation catheter
    • Dilator catheter
    • Manometry catheter
    • Nasobiliary drainage catheter
    • Nasopancreatic drainage catheter
    • Brush cytology catheter
  • Wires
  • Biopsy forceps
  • Stone extraction tools
    • Balloon
    • Stone retrieval baskets
    • Mechanical lithotriptor
  • Stents
    • Plastic stents
    • Metal stent
    • Covered metal stent
    • Uncovered metal stent[4]

Indications

Biliary Tract Diseases

Choledecholithiasis

  • ERCP is the treatment of choice for choledecholithiasis (or gallstones in the common bile duct).
  • Role of ERCP:
    • Dilatation of the sphincter of Oddi by endoscopic sphincterectomy and subsequent stone extraction.
      • Stone removal is done by balloons or wire baskets.
      • When the stones are too large to be extracted, lithotripsy can be done to fragment the stones.
    • Balloon sphincteroplasty is an alternative for sphincterectomy in patients with coagulopathies.[2]
Shown below is a fluoroscopic image of the common bile duct seen at the time of ERCP.
Fluoroscopic image of common bile duct stone seen at the time of ERCP. The stone is impacted in the distal common bile duct.
Fluoroscopic image of common bile duct stone seen at the time of ERCP. The stone is impacted in the distal common bile duct.

Biliary strictures or leak

  • ERCP is indicated in the treatment of biliary strictures and leak secondary to primary sclerosing cholangitis, chronic pancreatitis, congenital bile duct anomalies and pancreatic transplantation.
  • Role of ERCP:
    • Endoscopic dilatation by:
      • Graduated dilatation
      • Balloon
      • Stent placement
      • Combination of more than one of the previously listed techniques
    • Endoscopic brushing and biopsies to rule one malignancy in selected cases.

Pancreatic Diseases

Recurrent acute pancreatitis

  • ERCP allows the assessment for possible underlying anatomic etiologies causing recurrent pancreatitis. Underlying causes include abnormal ductal anatomy, pancreas divisum, increased tone of the sphincter of Oddi or microlithiasis.
  • Role of ERCP:
    • Stent placement
    • Sphincterctomy
    • Analysis of the bile looking for microlithiasis.

Chronic pancreatitis

  • Chronic pancreatitis is associated with pancreatic duct stones, strictures and pseudocysts.
  • Role of ERCP :
    • Pancreatic sphincterectomy and stone removal with/without lithotripsy
    • Dilatation and stent placement for the strictures
    • Pseucdocyst drainage

Pancreatic duct leaks

  • Pancreatic duct leaks are seen in acute pancreatitis, chronic pancreatitis, trauma or after surgery. If left untreated, pancreatic leaks lead to ascites and formation of pseudocysts.
  • Role of ERCP:
    • Transpapillary stent
    • "Bridging" by reconnecting segments of the pancreatic parenchyma

Pancreatic fluid collection

  • Pancreatic fluid collection can be either in the form of acute pseudocyst, chronic pseudocyst or pancreatic necrosis.
  • Role of ERCP:
    • Drainage by transpapillary therapy in communicable fluid collections
    • Drainage by transgastric or transduodenal therapy in non communicable fluid collections[2]

Pancreatic malignancies

  • ERCP is an adjunctive technique to contrast enhanced imaging in the the diagnosis of pancreatic malignancy.
  • Role of ERCP:
    • Palliative relief of obstruction
    • Brush cytology
    • Biopsy[2]
Shown below is a fluoroscopic image of the pancreatic duct seen at the time of ERCP.
Fluoroscopic image showing dilatation of the pancreatic duct during ERCP investigation. Endoscope is visible.
Fluoroscopic image showing dilatation of the pancreatic duct during ERCP investigation. Endoscope is visible.

Diseases of the Ampulla of Vater

Ampullary adenoma

  • Role of ERCP:
    • Snare ampillectomy with biliary or pancreatic sphincterectomy.

Dysfunction of the Sphincter of Oddi

Hypertonic Sphincter of Oddi

  • Increased tone of the sphincter of Oddi leads to obstruction of the bile and pancreatic secretion pathway and subsequent symptoms of biliary colic.
  • Role of ERCP:
    • Biliary manometry (diagnostic)
    • Biliary sphincterectomy (therapeutic)[2]

Contraindications

Absolute Contraindications

  • The uncooperative patient
  • Recent attack of acute pancreatitis, within the past several weeks
  • Recent myocardial infarction
  • Inadequate surgical back-up
  • History of contrast dye anaphylaxis
  • High risk of post-sphincterectomy bleeding

Relative Contraindications

  • Poor health condition for surgery
  • Severe cardiopulmonary disease
  • Ascites

Complications

Pancreatitis

Criteria

  • New or worsened abdominal pain, or
  • New or prolongation of hospitalization for two or more days, or
  • Increase in the serum amylase level at least three times the normal within 24 hours after ERCP[3]

Incidence

  • Pancreatitis is the most common complication associated with ERCP.
  • The incidence of pancreatitis is estimated to be around 3.5%, however 75 % of patients have elevated pancreatic enzymes in the absence of pancreatitis.[5]

Risk factors

In alphabetical order

  • Balloon dilation of biliary sphincter
  • History of post-ERCP pancreatitis
  • Normal bilirubin
  • Pancreatic duct injection
  • Precut sphincterotomy
  • Suspected sphincter of Oddi dysfunction
  • Young age[6]

Prevention

  • Substitution of ERCP with an alternative procedure in high risk patients when the chances of therapeutic benefits are low
  • Reduction of the ERCP-induced inflammation by prophylactic administration of indomethacin and diclofenac before ERCP
  • Placement of duct stents in high risk patients
  • The use of wire guided cannulation before injection of the dye to avoid the dye reaching the pancreas[3]

Hemorrhage

Criteria

  • Hemorrhage post-ERCP can be immediate or delayed (within two weeks).
  • Severity of post-ERCP is classified as follows:
    • Mild hemorrhage: endoscopic and clinical evidence of bleeding in the absence of need to transfusion and in the context of a drop in hemoglobin that does not exceed 3 g/dL.
    • Moderate hemorrhage: endoscopic and clinical evidence of bleeding that requires transfusion of 4 units or less, but not angiographic intervention or surgery.
    • Severe hemorrhage: endoscopic and clinical evidence of bleeding that requires transfusion of 5 units or more, or intervention angiographic or surgical) interventions.[7]

Incidence

  • The incidence of post-ERCP hemorrhage is around 1.3%. [8]

Risk factors

In alphabetical order

  • Acute cholangitis
  • Anticoagulation use within 72 hours
  • Coagulopathy
  • Papillary Stenosis
  • Sphincterectomy

The most important risk factor for post-ERCP hemorrhage is sphincterectomy . The length of incision as well as the use of antiplatelets and NSAIDS do not increase the risk of bleeding following ERCP.[3]

Treatment

  • Injection with epinephrine
  • Thermal therapy
  • Endoscopic clips[3]

Perforation

Criteria

  • Guidewire induced perforation, or
  • Luminal perforation at a site remote from the papilla, or
  • The perforation of the ampulla during sphincterectomy

Incidence

  • The incidence of post-ERCP perforation is between 0.1% and 0.6%.[9]

Risk factors

  • Sphincterectomy
  • Billroth II anatomy
  • Intramural injection of contrast
  • Prolonged duration of procedure
  • Dilatation of biliary stricture

Prevention

  • Biliary and duodenal drainage
  • Broad spectrum antibiotics[3]

Infection

Incidence

The incidence of cholangitis is less than 1%[10] and that of cholecystitis is between 0.2 and 0.6%[11]following ERCP.

Risk factors

  • Cholangitis:
    • Use of combined percutaneous-endoscopic procedures
    • Stent placement in malignant strictures
    • Presence of jaundice
    • Primary sclerosing cholangitis[12]
  • Cholecystitis:
    • Presence of stones in the gallbladder and possibly filling of the gallbladder with contrast during the examination
    • Use of self-expandable metal stents
    • Incomplete biliary drainage[11]

Prevention

  • Antibiotic prophylaxis covering gram negative bacteria and enterococci should be considered before an ERCP in patients with known or suspected biliary obstruction in which there is a risk of incomplete drainage by ERCP. This is usually the case of patients with primary sclerosing cholangitis.[3]

Cardiopulmonary Complications

Criteria

  • Cardiac arrhythmia
  • Hypoxemia
  • Aspiration[3]

Incidence

The incidence of cardiovascular complications is approximately 1%.

Risk factors

  • Advanced age
  • Procedures lasting more than 30 minutes[13]
  • Medications used for sedation and analgesia[3]

Prevention

  • Use of propofol in anesthesia[14]

Mortality

The mortality rate associated with ERCP is 0.2%.[15]

Antibiotic Prophylaxis

Antibiotic use before ERCP is recommended in:

  • Patients with known or suspected biliary obstruction and in which drainage might not be complete by ERCP (for example, in patients with a hilar stricture and PSC) in order to prevent cholangitis.
    • If biliary drainage is incomplete after an ERCP, antibiotics covering the biliary flora ( enteric gram-negative organisms and enterococci) should be continued following the procedure.
    • If biliary drainage is complete, antibiotics are not recommended after ERCP.
  • Patients with post-transplant biliary strictures whether drainage was complete or not.
  • Patients with communicating sterile pancreatic fluid collection such as pancreatic cysts or pseudocysts in order to prevent cyst infection.[16]

ERCP Versus MRCP

Videos

http://www.youtube.com/playlist?list=PL40886E113559E9E4&feature=plcp

http://www.youtube.com/watch?v=o-L4gdqOuPI&feature=related

See also

References

  1. McCune WS, Shorb PE, Moscovitz H. Endoscopic cannulation of the ampulla of Vater: a preliminary report. Ann Surg 1968;167:752-6.
  2. 2.0 2.1 2.2 2.3 2.4 Adler DG, Baron TH, Davila RE, Egan J, Hirota WK, Leighton JA; et al. (2005). "ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas". Gastrointest Endosc. 62 (1): 1–8. doi:10.1016/j.gie.2005.04.015. PMID 15990812.
  3. 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 ASGE Standards of Practice Committee. Anderson MA, Fisher L, Jain R, Evans JA, Appalaneni V; et al. (2012). "Complications of ERCP". Gastrointest Endosc. 75 (3): 467–73. doi:10.1016/j.gie.2011.07.010. PMID 22341094.
  4. asge.org
  5. AndriulliA,LoperfidoS,NapolitanoG,etal.Incidenceratesofpost-ERCP complications: a systematic survey of prospective studies. Am J Gastro- enterol 2007;102:1781-8.
  6. FreemanML.AdverseoutcomesofERCP.GastrointestEndosc2002;56(6 Suppl):S273-82.
  7. Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC; et al. (1991). "Endoscopic sphincterotomy complications and their management: an attempt at consensus". Gastrointest Endosc. 37 (3): 383–93. PMID 2070995.
  8. AndriulliA,LoperfidoS,NapolitanoG,etal.Incidenceratesofpost-ERCP complications: a systematic survey of prospective studies. Am J Gastro- enterol 2007;102:1781-8.
  9. FreemanML.AdverseoutcomesofERCP.GastrointestEndosc2002;56(6 Suppl):S273-82.
  10. FreemanML.AdverseoutcomesofERCP.GastrointestEndosc2002;56(6 Suppl):S273-82.
  11. 11.0 11.1 Fumex F, Coumaros D, Napoleon B, et al. Similar performance but higher cholecystitis rate with covered biliary stents: results from a prospective multicenter evaluation. Endoscopy 2006;38:787-92.
  12. FreemanML.AdverseoutcomesofERCP.GastrointestEndosc2002;56(6 Suppl):S273-82.
  13. Fisher L, Fisher A, Thomson A. Cardiopulmonary complications of ERCP in older patients. Gastrointest Endosc 2006;63:948-55
  14. Cote GA, Hovis RM, Ansstas MA, et al. Incidence of sedation-related complications with propofol use during advanced endoscopic proce- dures. Clin Gastroenterol Hepatol 2010;8:137-42.
  15. Loperfido S, Angelini G, Benedetti G, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998;48:1-10.
  16. ASGE STANDARDS OF PRACTICE COMMITTEE. Banerjee S, Shen B, Baron TH, Nelson DB, Anderson MA; et al. (2008). "Antibiotic prophylaxis for GI endoscopy". Gastrointest Endosc. 67 (6): 791–8. doi:10.1016/j.gie.2008.02.068. PMID 18374919.


de:Endoskopisch retrograde Cholangiopankreatikographie nl:Endoscopische retrograde cholangiopancreatografie fi:Endoskooppinen retrogradinen kolangiopankreatikografia sv:ERCP

Template:Jb1

Template:WikiDoc Sources